BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6615847)

  • 1. The cohydrolases in human spleen that stimulate glucosyl ceramide beta-glucosidase.
    Iyer SS; Berent SL; Radin NS
    Biochim Biophys Acta; 1983 Oct; 748(1):1-7. PubMed ID: 6615847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on glucocerebrosidase in spleens from patients with Gaucher disease.
    Aerts JM; Donker-Koopman WE; Brul S; Van Weely S; Sa Miranda MC; Barranger JA; Tager JM; Schram AW
    Biochem J; 1990 Jul; 269(1):93-100. PubMed ID: 2198026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Properties of the molecular forms of beta-glucosidase and beta-glucocerebrosidase from normal human and Gaucher disease spleen (author's transl)].
    Maret A; Salvayre R; Negre A; Douste-Blazy L
    Eur J Biochem; 1981 Apr; 115(3):455-61. PubMed ID: 6786882
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of the glucosidase-stimulating proteins by competitive enzyme-linked immunoassay.
    Datta SC; Radin NS
    Anal Biochem; 1984 Oct; 142(1):196-203. PubMed ID: 6393820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A kinetic study of the effects of galactocerebroside 3-sulphate on human spleen glucocerebrosidase. Evidence for two activator-binding sites.
    Prence EM; Garrett KO; Glew RH
    Biochem J; 1986 Aug; 237(3):655-62. PubMed ID: 3800908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gaucher disease: isolation and comparison of normal and mutant glucocerebrosidase from human spleen tissue.
    Pentchev PG; Brady RO; Blair HE; Britton DE; Sorrell SH
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3970-3. PubMed ID: 29293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a heat-stable factor in human placenta on glucosylceramidase, glucosylsphingosine glucosyl hydrolase, and acid beta-glucosidase activities.
    Vaccaro AM; Muscillo M; Tatti M; Salvioli R; Gallozzi E; Suzuki K
    Clin Biochem; 1987 Dec; 20(6):429-33. PubMed ID: 3124976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucosylceramide and the level of the glucosidase-stimulating proteins.
    Datta SC; Radin NS
    Lipids; 1986 Nov; 21(11):702-9. PubMed ID: 3099116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular localization of the heat-stable glucocerebrosidase activator substance in Gaucher spleen.
    Chiao YB; Chambers JP; Glew RH; Lee RE; Wenger DA
    Arch Biochem Biophys; 1978 Feb; 186(1):42-51. PubMed ID: 629536
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple forms of beta-glucosidase in Gaucher disease.
    Yaqoob M; Carroll M
    Prog Clin Biol Res; 1982; 95():453-63. PubMed ID: 6812081
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of activation of glucocerebrosidase by co-beta-glucosidase (glucosidase activator protein).
    Berent SL; Radin NS
    Biochim Biophys Acta; 1981 Jun; 664(3):572-82. PubMed ID: 6268176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in human acid beta-glucosidase revealed by cellulose-acetate electrophoresis.
    Sa Miranda MC; Aerts JM; Pinto RA; Magalhaes JA; Barranger JA; Tager JM; Schram AW
    Biochim Biophys Acta; 1988 May; 965(2-3):163-8. PubMed ID: 3130106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
    Gatt S; Dinur T; Osiecki K; Desnick RJ; Grabowski GA
    Enzyme; 1985; 33(2):109-19. PubMed ID: 3924590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of subunit interaction in membrane-bound acid beta-glucosidase from Gaucher disease.
    Maret A; Potier M; Salvayre R; Douste-Blazy L
    FEBS Lett; 1983 Aug; 160(1-2):93-7. PubMed ID: 6411492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human acid beta-glucosidase: inhibition studies using glucose analogues and pH variation to characterize the normal and Gaucher disease glycon binding sites.
    Osiecki-Newman K; Legler G; Grace M; Dinur T; Gatt S; Desnick RJ; Grabowski GA
    Enzyme; 1988; 40(4):173-88. PubMed ID: 3234317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical and kinetic properties of beta-glucosidase in Gaucher disease.
    Karazeh A; Carroll M
    J Inherit Metab Dis; 1983; 6(3):101-4. PubMed ID: 6422137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate.
    Peters SP; Coyle P; Glew RH
    Arch Biochem Biophys; 1976 Aug; 175(2):569-82. PubMed ID: 958319
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro detergent activation of lysosomal acid beta-glucosidase in the spleen of normal and type 1 Gaucher patients is not accompanied by change in aggregation state.
    Maret A; Potier M; Salvayre R; Troly M; Beauregard G; Douste-Blazy L
    Biochim Biophys Acta; 1989 Jul; 996(3):254-6. PubMed ID: 2502183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of activator proteins for the enzymatic degradation of glucosylceramide in several human tissues.
    Vaccaro AM; Ciaffoni F; Mandara I; Suzuki K
    Clin Chim Acta; 1988 Mar; 172(2-3):323-34. PubMed ID: 3370844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of heat-stable glucocerebrosidase activators from the spleens of three variants of Gaucher's disease.
    Peters SP; Coffee CJ; Glew RH; Lee RE; Wenger DA; Li SC; Li YT
    Arch Biochem Biophys; 1977 Sep; 183(1):290-7. PubMed ID: 907355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.